Zusammenfassung
Hämatopoetische Stammzellen (HSC) sind im Knochenmark in einem hoch spezialisierten Mikromilieu, der sog. Nische, lokalisiert. Diese setzt sich aus zellulären Bestandteilen, wie z. B. mesenchymalen Stromazellen (MSC), Osteoblasten und Endothelzellen, sowie extrazellulärer Matrix und löslichen Faktoren zusammen. Auch für disseminierte Tumorzellen stellt die Nische eine attraktive Umgebung dar, um sich therapeutischen Ansätzen zu entziehen, zu proliferieren oder auch in einen Ruhezustand zu verfallen. Für diese Prozesse sind molekulare Interaktionen zwischen Tumorzellen und den Stamm- und Vorläuferzellen im Knochenmark von Bedeutung, die u. a. durch Integrine oder Chemokine wie stromal-derived factor-1 (SDF-1) vermittelt werden. Auch verschiedene Immunzellen können eine den Tumor unterstützenden Wirkung haben. Die Konkurrenz zwischen Tumorzellen und HSC in der Nische resultiert teilweise in der Verdrängung unreifer Vorläuferzellen in das periphere Blut der Patienten.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
Literatur
Basu S, Ray NT, Atkinson SJ, Broxmeyer HE (2007) Protein phosphatase 2A plays an important role in stromal cell-derived factor-1/CXC chemokine ligand 12-mediated migration and adhesion of CD34+ cells. J Immunol 179: 3075–3085
Bewick MA, Lafrenie RM (2006) Adhesion dependent signalling in the tumour microenvironment: the future of drug targeting. Curr Pharm Des 12: 2833–2848
Broxmeyer HE (2008) Chemokines in hematopoiesis. Curr Opin Hematol 15: 49–58
Broxmeyer HE, Orschell CM, Clapp DW et al (2005) Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist. J Exp Med 201: 1307–1318
Chabanon A, Desterke C, Rodenburger E et al (2008) A cross-talk between stromal cell-derived factor-1 and transforming growth factor-beta controls the quiescence/cycling switch of CD34(+) progenitors through FoxO3 and mammalian target of rapamycin. Stem Cells 26: 3150–3161
Coleman RE (2006) Clinical features of metastatic bone disease and risk of skeletal morbidity. Clin Cancer Res 12: 6243s–6249s
Decker T, Fischer G, Bucke W et al (2012) Increased number of regulatory T cells (T-regs) in the peripheral blood of patients with Her-2/neu-positive early breast cancer. J Cancer Res Clin Oncol 138: 1945–1950
Deguchi K, Yagi H, Inada M et al (1999) Excessive extramedullary hematopoiesis in Cbfa1-deficient mice with a congenital lack of bone marrow. Biochem Biophys Res Commun 255: 352–359
Ding L, Saunders TL, Enikolopov G, Morrison SJ (2012) Endothelial and perivascular cells maintain haematopoietic stem cells. Nature 481: 457–462
Ehninger A, Trumpp A (2011) The bone marrow stem cell niche grows up: mesenchymal stem cells and macrophages move in. J Exp Med 208: 421–428
Fujisaki J, Wu J, Carlson AL et al (2011) In vivo imaging of Treg cells providing immune privilege to the haematopoietic stem-cell niche. Nature 474: 216–219
Fukuda S, Broxmeyer HE, Pelus LM (2005) Flt3 ligand and the Flt3 receptor regulate hematopoietic cell migration by modulating the SDF-1alpha(CXCL12)/CXCR4 axis. Blood 105: 3117–3126
Havens AM, Jung Y, Sun YX et al (2006) The role of sialomucin CD164 (MGC-24v or endolyn) in prostate cancer metastasis. BMC Cancer 6: 195
Havens AM, Pedersen EA, Shiozawa Y et al (2008) An in vivo mouse model for human prostate cancer metastasis. Neoplasia 10: 371–380
Jin DK, Shido K, Kopp HG et al (2006) Cytokine-mediated deployment of SDF-1 induces revascularization through recruitment of CXCR4+ hemangiocytes. Nat Med 12: 557–567
Kang Y, Siegel PM, Shu W et al (2003) A multigenic program mediating breast cancer metastasis to bone. Cancer Cell 3: 537–549
Kaplan RN, Riba RD, Zacharoulis S et al (2005) VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature 438: 820–827
Li XF, O’Donoghue JA (2008) Hypoxia in microscopic tumors. Cancer Lett 264: 172–180
Logothetis CJ, Lin SH (2005) Osteoblasts in prostate cancer metastasis to bone. Nat Rev Cancer 5: 21–28
Lord BI, Testa NG, Hendry JH (1975) The relative spatial distributions of CFUs and CFUc in the normal mouse femur. Blood 46: 65–72
Melani C, Sangaletti S, Barazzetta FM et al (2007) Amino-biphosphonate-mediated MMP-9 inhibition breaks the tumor-bone marrow axis responsible for myeloid-derived suppressor cell expansion and macrophage infiltration in tumor stroma. Cancer Res 67: 11438–11446
Mendez-Ferrer S, Michurina TV, Ferraro F et al (2010) Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature 466: 829–834
Movahedi K, Guilliams M, Van den Bossche J et al (2008) Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity. Blood 111: 4233–4244
Nilsson SK, Johnston HM, Coverdale JA (2001) Spatial localization of transplanted hemopoietic stem cells: inferences for the localization of stem cell niches. Blood 97: 2293–2299
Paget S (1889) The distribution of secondary growths in cancer of the breast. Lancet 8: 98–101
Pantel K, Brakenhoff RH (2004) Dissecting the metastatic cascade. Nat Rev Cancer 4: 448–456
Petit I, Szyper-Kravitz M, Nagler A et al (2002) G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4. Nat Immunol 3: 687–694
Pienta KJ, McGregor N, Axelrod R, Axelrod DE (2008) Ecological therapy for cancer: defining tumors using an ecosystem paradigm suggests new opportunities for novel cancer treatments. Transl Oncol 1: 158–164
Ramasamy R, Lam EW, Soeiro I et al (2007) Mesenchymal stem cells inhibit proliferation and apoptosis of tumor cells: impact on in vivo tumor growth. Leukemia 21: 304–310
Schofield R (1978) The relationship between the spleen colony-forming cell and the haemopoietic stem cell. Blood Cells 4: 7–25
Shiozawa Y, Havens AM, Jung Y et al (2008) Annexin II/annexin II receptor axis regulates adhesion, migration, homing, and growth of prostate cancer. J Cell Biochem 105: 370–380
Shiozawa Y, Pedersen EA, Havens AM et al (2011a) Human prostate cancer metastases target the hematopoietic stem cell niche to establish footholds in mouse bone marrow. J Clin Invest 121: 1298–1312
Shiozawa Y, Pienta KJ, Taichman RS (2011b) Hematopoietic stem cell niche is a potential therapeutic target for bone metastatic tumors. Clin Cancer Res 17: 5553–5558
Simsek T, Kocabas F, Zheng J et al (2010) The distinct metabolic profile of hematopoietic stem cells reflects their location in a hypoxic niche. Cell Stem Cell 7: 380–390
Sun YX, Pedersen EA, Shiozawa Y et al (2008) CD26/dipeptidyl peptidase IV regulates prostate cancer metastasis by degrading SDF-1/CXCL12. Clin Exp Metastasis 25: 765–776
Taichman RS (2005) Blood and bone: two tissues whose fates are intertwined to create the hematopoietic stem-cell niche. Blood 105: 2631–2639
Taichman RS, Emerson SG (1998) The role of osteoblasts in the hematopoietic microenvironment. Stem Cells 16: 7–15
Takubo K, Goda N, Yamada W et al (2010) Regulation of the HIF-1alpha level is essential for hematopoietic stem cells. Cell Stem Cell 7: 391–402
Wang J, Wang J, Sun Y et al (2005) Diverse signaling pathways through the SDF-1/CXCR4 chemokine axis in prostate cancer cell lines leads to altered patterns of cytokine secretion and angiogenesis. Cell Signal 17: 1578–1592
Wang J, Wang J, Dai J et al (2007) A glycolytic mechanism regulating an angiogenic switch in prostate cancer. Cancer Res 67: 149–159
Weigelt B, Peterse JL, van’t Veer LJ (2005) Breast cancer metastasis: markers and models. Nat Rev Cancer 5: 591–602
Weilbaecher KN, Guise TA, McCauley LK (2011) Cancer to bone: a fatal attraction. Nat Rev Cancer 11: 411–425
Wilson A, Trumpp A (2006) Bone-marrow haematopoietic-stem-cell niches. Nat Rev Immunol 6: 93–106
Yang L, Edwards CM, Mundy GR (2010) Gr-1+CD11b+ myeloid-derived suppressor cells: formidable partners in tumor metastasis. J Bone Miner Res 25: 1701–1706
Zhang XF, Wang JF, Matczak E et al (2001) Janus kinase 2 is involved in stromal cell-derived factor-1alpha-induced tyrosine phosphorylation of focal adhesion proteins and migration of hematopoietic progenitor cells. Blood 97: 3342–3348
Zhao S, Wehner R, Bornhauser M et al (2010) Immunomodulatory properties of mesenchymal stromal cells and their therapeutic consequences for immune-mediated disorders. Stem Cells Dev 19: 607–614
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Wobus, M., Bornhäuser, M. (2014). Interaktion von disseminierten Tumorzellen mit Stamm- und Immunzellen im prämetastatischen Knochenmarkmilieu. In: Stenzl, A., Fehm, T., Hofbauer, L., Jakob, F. (eds) Knochenmetastasen. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-43471-0_1
Download citation
DOI: https://doi.org/10.1007/978-3-662-43471-0_1
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-43470-3
Online ISBN: 978-3-662-43471-0
eBook Packages: Medicine (German Language)